BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31558459)

  • 1. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.
    Lynam A; McDonald T; Hill A; Dennis J; Oram R; Pearson E; Weedon M; Hattersley A; Owen K; Shields B; Jones A
    BMJ Open; 2019 Sep; 9(9):e031586. PubMed ID: 31558459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.
    Carr ALJ; Perry DJ; Lynam AL; Chamala S; Flaxman CS; Sharp SA; Ferrat LA; Jones AG; Beery ML; Jacobsen LM; Wasserfall CH; Campbell-Thompson ML; Kusmartseva I; Posgai A; Schatz DA; Atkinson MA; Brusko TM; Richardson SJ; Shields BM; Oram RA
    Diabet Med; 2020 Dec; 37(12):2160-2168. PubMed ID: 32634859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.
    Katulanda P; Shine B; Katulanda GW; Silva A; Asfir EL; Sheriff R; Somasundaram N; Long AE; Bingley PJ; McCarthy MI; Clark A; Matthews DR
    Diabetologia; 2008 Aug; 51(8):1368-74. PubMed ID: 18528678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.
    Grubb AL; McDonald TJ; Rutters F; Donnelly LA; Hattersley AT; Oram RA; Palmer CNA; van der Heijden AA; Carr F; Elders PJM; Weedon MN; Slieker RC; 't Hart LM; Pearson ER; Shields BM; Jones AG
    Diabetes Care; 2019 Feb; 42(2):208-214. PubMed ID: 30352895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis.
    Hope SV; Wienand-Barnett S; Shepherd M; King SM; Fox C; Khunti K; Oram RA; Knight BA; Hattersley AT; Jones AG; Shields BM
    Br J Gen Pract; 2016 May; 66(646):e315-22. PubMed ID: 27080317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of European prediction models for classification of type 1 and type 2 diabetes in Indians.
    Venkatesan U; Amutha A; Jones AG; Shields BM; Anjana RM; Unnikrishnan R; Mappillairaju B; Mohan V
    Diabetes Metab Syndr; 2024 Apr; 18(4):103007. PubMed ID: 38636306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
    Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
    Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.
    Thomas NJ; Lynam AL; Hill AV; Weedon MN; Shields BM; Oram RA; McDonald TJ; Hattersley AT; Jones AG
    Diabetologia; 2019 Jul; 62(7):1167-1172. PubMed ID: 30969375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
    Calsolari MR; Rosário PW; Reis JS; Silva SC; Purisch S
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):315-21. PubMed ID: 18438542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
    Hawa MI; Buchan AP; Ola T; Wun CC; DeMicco DA; Bao W; Betteridge DJ; Durrington PN; Fuller JH; Neil HA; Colhoun H; Leslie RD; Hitman GA
    Diabetes Care; 2014 Jun; 37(6):1643-9. PubMed ID: 24722498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
    Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the Chinese Expert Consensus on Diabetes Classification in clinical practice].
    Yang ST; Deng C; He BB; Chen X; Li X; Zhou ZG
    Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1085-1092. PubMed ID: 37650182
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.
    Li X; Yang S; Cao C; Yan X; Zheng L; Zheng L; Da J; Tang X; Ji L; Yang X; Zhou Z
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32808015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.